受强制性开放获取政策约束的文章 - Evlambia Hajishengallis Harokopakis了解详情
无法在其他位置公开访问的文章：1 篇
Milk fat globule epidermal growth factor 8 inhibits periodontitis in non‐human primates and its gingival crevicular fluid levels can differentiate periodontal health from …
T Kajikawa, F Meshikhes, T Maekawa, E Hajishengallis, KB Hosur, T Abe, ...
Journal of clinical periodontology 44 (5), 472-483, 2017
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：22 篇
Advances in the microbial etiology and pathogenesis of early childhood caries
E Hajishengallis, Y Parsaei, MI Klein, H Koo
Molecular oral microbiology 32 (1), 24-34, 2017
强制性开放获取政策： US National Institutes of Health
Candida albicans and Early Childhood Caries: A Systematic Review and Meta-Analysis
J Xiao, X Huang, N Alkhers, H Alzamil, S Alzoubi, TT Wu, DA Castillo, ...
Caries research 52 (1-2), 102-112, 2018
强制性开放获取政策： US National Institutes of Health
Neutrophil homeostasis and periodontal health in children and adults
E Hajishengallis, G Hajishengallis
Journal of dental research 93 (3), 231-237, 2014
强制性开放获取政策： US National Institutes of Health
Spatial mapping of polymicrobial communities reveals a precise biogeography associated with human dental caries
D Kim, JP Barraza, RA Arthur, A Hara, K Lewis, Y Liu, EL Scisci, ...
Proceedings of the National Academy of Sciences 117 (22), 12375-12386, 2020
强制性开放获取政策： US National Institutes of Health, Wellcome Trust
Neutrophil homeostasis and inflammation: novel paradigms from studying periodontitis
G Hajishengallis, T Chavakis, E Hajishengallis, JD Lambris
Journal of Leucocyte Biology 98 (4), 539-548, 2015
强制性开放获取政策： US National Institutes of Health, German Research Foundation, European …
Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist
T Abe, KB Hosur, E Hajishengallis, ES Reis, D Ricklin, JD Lambris, ...
The Journal of Immunology 189 (11), 5442-5448, 2012
强制性开放获取政策： US National Institutes of Health
Immune and regulatory functions of neutrophils in inflammatory bone loss
G Hajishengallis, NM Moutsopoulos, E Hajishengallis, T Chavakis
Seminars in immunology 28 (2), 146-158, 2016
强制性开放获取政策： US National Institutes of Health
Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis
T Maekawa, T Abe, E Hajishengallis, KB Hosur, RA DeAngelis, D Ricklin, ...
The Journal of Immunology 192 (12), 6020-6027, 2014
强制性开放获取政策： US National Institutes of Health, European Commission
Role of complement in host–microbe homeostasis of the periodontium
G Hajishengallis, T Abe, T Maekawa, E Hajishengallis, JD Lambris
Seminars in immunology 25 (1), 65-72, 2013
强制性开放获取政策： US National Institutes of Health
DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates
J Shin, T Maekawa, T Abe, E Hajishengallis, K Hosur, K Pyaram, ...
Science translational medicine 7 (307), 307ra155-307ra155, 2015
强制性开放获取政策： US National Institutes of Health, German Research Foundation, European …
Complement-dependent mechanisms and interventions in periodontal disease
G Hajishengallis, T Kajikawa, E Hajishengallis, T Maekawa, ES Reis, ...
Frontiers in immunology 10, 406, 2019
强制性开放获取政策： US National Institutes of Health
Complement involvement in periodontitis: molecular mechanisms and rational therapeutic approaches
G Hajishengallis, T Maekawa, T Abe, E Hajishengallis, JD Lambris
Immune Responses to Biosurfaces: Mechanisms and Therapeutic Interventions, 57-74, 2015
强制性开放获取政策： US National Institutes of Health
Inhibition of pre‐existing natural periodontitis in non‐human primates by a locally administered peptide inhibitor of complement C3
T Maekawa, RA Briones, RRG Resuello, JV Tuplano, E Hajishengallis, ...
Journal of clinical periodontology 43 (3), 238-249, 2016
强制性开放获取政策： US National Institutes of Health
Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application
G Hajishengallis, E Hajishengallis, T Kajikawa, B Wang, D Yancopoulou, ...
Seminars in immunology 28 (3), 285-291, 2016
强制性开放获取政策： US National Institutes of Health
Complement therapeutics in inflammatory diseases: promising drug candidates for C3‐targeted intervention
DC Mastellos, D Ricklin, E Hajishengallis, G Hajishengallis, JD Lambris
Molecular oral microbiology 31 (1), 3-17, 2016
强制性开放获取政策： US National Institutes of Health
C3-targeted therapy in periodontal disease: moving closer to the clinic
G Hajishengallis, H Hasturk, JD Lambris, DA Apatzidou, GN Belibasakis, ...
Trends in immunology 42 (10), 856-864, 2021
强制性开放获取政策： US National Institutes of Health
Safety and efficacy of the complement inhibitor AMY-101 in a natural model of periodontitis in non-human primates
T Kajikawa, RA Briones, RRG Resuello, JV Tuplano, ES Reis, ...
Molecular Therapy Methods & Clinical Development 6, 207-215, 2017
强制性开放获取政策： US National Institutes of Health
Multiple idiopathic cervical root resorption: a challenge for a transdisciplinary medical-dental team
EY Chu, JG Deeb, BL Foster, E Hajishengallis, MJ Somerman, ...
Frontiers in dental medicine 2, 652605, 2021
强制性开放获取政策： US National Institutes of Health
Retrospective analysis of Candida-related conditions in infancy and early childhood caries
J Jean, S Goldberg, R Khare, LC Bailey, CB Forrest, E Hajishengallis, ...
Pediatric dentistry 40 (2), 131-135, 2018
强制性开放获取政策： US National Institutes of Health, Patient-Centered Outcomes Research Institute
出版信息和资助信息由计算机程序自动确定